Advanced search
Publication Cover
Nanomedicine Volume 5, 2010 - Issue 3
Submit an article Journal homepage
1,107
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Curcumin-Encapsulated MePEG/PCL Diblock Copolymeric Micelles: A Novel Controlled Delivery Vehicle for Cancer Therapy

Chandana MohantyView further author information
,
Sarbari AcharyaView further author information
,
Anjan K MohantyView further author information
,
Fahima DilnawazView further author information
&
Sanjeeb K SahooLaboratory for Nanomedicine, Institute of Life Sciences, Nalco Square, Chandrasekharpur, Bhubaneswar, Orissa, India.Correspondence[email protected]
View further author information
Pages 433-449 | Published online: 16 Apr 2010

Bibliography

  • Erkan M , KleeffJ, EspositoIet al.: Loss of bnip3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis.Oncogene24(27), 4421–4432 (2005).
  • Fryer RA , GalustianC, DalgelishAG: Recent advances and developments in treatment strategies against pancreatic cancer.Curr. Clin. Pharmacol.4(2), 102–112 (2009).
  • Anand P , KunnumakkaraAB, NewmanRA, AggarwalBB: Bioavailability of curcumin: problems and promises.Mol. Pharm.4(6), 807–818 (2007).
  • Somasundaram S , EdmundNA, MooreDT, SmallGW, ShiYY, OrlowskiRZ: Dietary curcumin inhibits chemotherapy-induced apoptosis in human models of human breast cancer.Cancer Res.62(13), 3868–3875 (2002).
  • Aggarwal BB , KumarA, BhartiAC: Anticancer potential of curcumin: preclinical and clinical studies.Anticancer Res.23(1A), 363–398 (2003).
  • Aggarwal BB , SungB: Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets.Trends Pharmacol. Sci.30(2), 85–94 (2009).
  • Cohen AN , VeenaMS, SrivatsanES, WangMB: Suppression of interleukin 6 and 8 production in head and neck cancer cells with curcumin via inhibition of iκβ kinase.Arch. Otolaryngol. Head Neck Surg.135(2), 190–197 (2009).
  • Farombi EO , ShrotriyaS, SurhYJ: Kolaviron inhibits dimethyl nitrosamine-induced liver injury by suppressing cox-2 and inos expression via NF-κB and AP-1.Life Sci.84(5–6), 149–155 (2009).
  • Owens DE 3rd, Peppas NA: Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm.307(1), 93–102 (2006).
  • Bisht S , FeldmannG, SoniSet al.: Polymeric nanoparticle-encapsulated curcumin (“Nanocurcumin”): a novel strategy for human cancer therapy.J. Nanobiotechnology5, 3 (2007).
  • Suresh D , SrinivasanK: Studies on the in vitro absorption of spice principles – curcumin, capsaicin and piperine in rat intestines.Food Chem. Toxicol.45(8), 1437–1442 (2007).
  • Ma Z , HaddadiA, MolaviO, LavasanifarA, LaiR, SamuelJ: Micelles of poly(ethylene oxide)-b-poly(ε-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin.J. Biomed. Mater. Res. A86(2), 300–310 (2008).
  • Sahu A , KasojuN, BoraU: Fluorescence study of the curcumin-casein micelle complexation and its application as a drug nanocarrier to cancer cells.Biomacromolecules9(10), 2905–2912 (2008).
  • Torchilin VP : Structure and design of polymeric surfactant-based drug delivery systems.J. Control Release73(2–3), 137–172 (2001).
  • Lavasanifar A , SamuelJ, KwonGS: Poly(ethylene oxide)-block-poly(l-amino acid) micelles for drug delivery.Adv. Drug Deliv. Rev.54(2), 169–190 (2002).
  • Creamer LK , PlowmanJE, LiddellMJ, SmithMH, HillJP: Micelle stability: κ-casein structure and function.J. Dairy Sci.81(11), 3004–3012 (1998).
  • Park EK , LeeSB, LeeYM: Preparation and characterization of methoxy poly(ethylene glycol)/poly(ε-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs.Biomaterials26(9), 1053–1061 (2005).
  • Torchilin VP : Micellar nanocarriers: pharmaceutical perspectives.Pharm. Res.24(1), 1–16 (2007).
  • Berrada M , SerreqiA, DabbarhF, OwusuA, GuptaA, LehnertS: A novel non-toxic camptothecin formulation for cancer chemotherapy.Biomaterials26(14), 2115–2120 (2005).
  • Letchford K , ZastreJ, LigginsR, BurtH: Synthesis and micellar characterization of short block length methoxy poly(ethylene glycol)-block-poly(caprolactone) diblock copolymers.Colloids Surf. B Biointerfaces35(2), 81–91 (2004).
  • Mohanty AK , DilnawazF, SahooSK: A biodegradable amphiphilic methoxy (poly ethylene glycol) and poly (ε caprolactone) copolymeric micelles loaded with etoposide as drug delivery vehicle for pancreatic cell line.Drug Delivery (2010) (In press).
  • Zhou S , DengX, YangH: Biodegradable poly(ε-caprolactone)-poly(ethylene glycol) block copolymers: characterization and their use as drug carriers for a controlled delivery system.Biomaterials24(20), 3563–3570 (2003).
  • Bong PH : Spectral and photophysical behaviors of curcumin and curcuminoids.Bull. Korean Chem. Soc.21(1), 81–86 (2000).
  • Chignell CF , BilskiP, ReszkaKJ, MottenAG, SikRH, DahlTA: Spectral and photochemical properties of curcumin.Photochem. Photobiol.59(3), 295–302 (1994).
  • Khopde SM , PriyadarsiniKI, PalitDK, MukherjeeT: Effect of solvent on the excited-state photophysical properties of curcumin.Photochem. Photobiol.72(5), 625–631 (2000).
  • Misra R , AcharyaS, DilnawazF, SahooSK: Sustained antibacterial activity of doxycycline-loaded poly(D,L-lactide-co-glycolide) and poly(ε-caprolactone) nanoparticles.Nanomedicine (Lond.)4(5), 519–530 (2009).
  • Acharya S , DilnawazF, SahooSK: Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy.Biomaterials30(29), 5737–5750 (2009).
  • Sahoo SK , MaW, LabhasetwarV: Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer.Int. J. Cancer112(2), 335–340 (2004).
  • Kunwar A , BarikA, MishraB, RathinasamyK, PandeyR, PriyadarsiniKI: Quantitative cellular uptake, localization and cytotoxicity of curcumin in normal and tumor cells.Biochim. Biophys. Acta1780(4), 673–679 (2008).
  • Lev-Ari S , VexlerA, StarrAet al.: Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines.Cancer Invest.25(6), 411–418 (2007).
  • Shin IG , KimSY, LeeYM, ChoCS, SungYK: Methoxy poly(ethylene glycol)/ε-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterization.J. Control Release51(1), 1–11 (1998).
  • Shuai X , AiH, NasongklaN, KimS, GaoJ: Micellar carriers based on block copolymers of poly(ε-caprolactone) and poly(ethylene glycol) for doxorubicin delivery.J. Control Release98(3), 415–426 (2004).
  • Kim SY , ShinIG, LeeYM, ChoCS, SungYK: Methoxy poly(ethylene glycol) and ε-caprolactone amphiphilic block copolymeric micelle containing indomethacin. II. Micelle formation and drug release behaviours.J. Control Release51(1), 13–22 (1998).
  • Yokoyama M , OkanoT, SakuraiY, EkimotoH, ShibazakiC, KataokaK: Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood.Cancer Res.51(12), 3229–3236 (1991).
  • Maeda H , WuJ, SawaT, MatsumuraY, HoriK: Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.J. Control Release65(1–2), 271–284 (2000).
  • Kim SY , ShinIG, LeeYM: Preparation and characterization of biodegradable nanospheres composed of methoxy poly(ethylene glycol) and dl-lactide block copolymer as novel drug carriers.J. Control Release56(1–3), 197–208 (1998).
  • Baimark Y : Surfactant-free nanospheres of methoxy poly (ethylene glycol)-b-poly (ε-caprolactone) for controlled release of ibuprofen.J. Appl. Sci.9(12), 2287–2293 (2009).
  • Yueying H , YanZ, ChunhuaG, WeifengD, MeidongL: Micellar carrier based on methoxy poly(ethylene glycol)-block-poly(ε-caprolactone) block copolymers bearing ketone groups on the polyester block for doxorubicin delivery.J. Mater. Sci. Mater. Med.21(2), 567–574 (2010).
  • Adhikary R , MukherjeeP, KeeTW, PetrichJW: Excited-state intramolecular hydrogen atom transfer and solvation dynamics of the medicinal pigment curcumin.J. Phys. Chem. B113(15), 5255–5261 (2009).
  • Leung MH , KeeTW: Effective stabilization of curcumin by association to plasma proteins: human serum albumin and fibrinogen.Langmuir25(10), 5773–5777 (2009).
  • Wang YJ , PanMH, ChengALet al.: Stability of curcumin in buffer solutions and characterization of its degradation products.J. Pharm. Biomed. Anal.15(12), 1867–1876 (1997).
  • Shaikh J , AnkolaDD, BeniwalV, SinghD, KumarMN: Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer.Eur. J. Pharm. Sci.37(3–4), 223–230 (2009).
  • Lev-Ari S , StrierL, KazanovDet al.: Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells.Rheumatology (Oxford)45(2), 171–177 (2006).
  • Lev-Ari S , StrierL, KazanovDet al.: Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.Clin. Cancer Res.11(18), 6738–6744 (2005).
  • Wang YZ , FangXL, LiYJ, ZhangZW, HanLM, ShaXY: preparation, characterization of paclitaxel-loaded pluronic p105 polymeric micelles and in vitro reversal of multidrug resistant tumor.Yao Xue Xue Bao43(6), 640–646 (2008).
  • Ganta S , AmijiM: Coadministration of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells.Mol. Pharm.6(3), 928–939 (2009).
  • Jiang H , DengCS, ZhangM, XiaJ: Curcumin-attenuated trinitrobenzene sulphonic acid induces chronic colitis by inhibiting expression of cyclooxygenase-2.World J. Gastroenterol.12(24), 3848–3853 (2006).
  • Momand J , ZambettiGP, OlsonDC, GeorgeD, LevineAJ: The MDM-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.Cell69(7), 1237–1245 (1992).
  • Rayburn ER , ZhangR: Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible?Drug Discov. Today13(11–12), 513–521 (2008).
  • Wang H , YuD, AgrawalS, ZhangR: Experimental therapy of human prostate cancer by inhibiting MDM2 expression with novel mixed-backbone antisense oligonucleotides: in vitro and in vivo activities and mechanisms.Prostate54(3), 194–205 (2003).
  • Zhang Z , ZhangR: p53-independent activities of MDM2 and their relevance to cancer therapy.Curr. Cancer Drug Targets5(1), 9–20 (2005).
  • Wang W , RayburnER, ZhaoY, WangH, ZhangR: Novel ginsenosides 25-OH-PPD and 25-OCH3-PPD as experimental therapy for pancreatic cancer: anticancer activity and mechanisms of action.Cancer Lett.278(2), 241–248 (2009).
  • Chen HW , HuangHC: Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells.Br. J. Pharmacol.124(6), 1029–1040 (1998).
  • Hermeking H , EickD: Mediation of c-myc-induced apoptosis by p53.Science265(5181), 2091–2093 (1994).
  • Sakamuro D , EvinerV, ElliottKJ, ShoweL, WhiteE, PrendergastGC: C-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms.Oncogene11(11), 2411–2418 (1995).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.